Lataa...
Metabolic Consequences of Oral Administration of 24,25-Dihydroxycholecalciferol to Uremic Dogs
24,25-dihydroxycholecalciferol [24,25-(OH)(2)D(3)], once considered a relatively inert metabolite of vitamin D(3), has been recently recognized as a metabolically active product in some species. In previous studies, we have shown that infusion of 24,25(OH)(2)D(3) into the thyroid artery of normal do...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
1980
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7354130/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109701 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|